agilon health(US:AGL) Globenewswire·2026-02-19 23:00Core Viewpoint - A class action lawsuit has been filed against agilon health, inc. for allegedly making false statements and failing to disclose critical information regarding its financial guidance and the impact of strategic actions taken by the company [4]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased agilon securities between February 26, 2025, and August 4, 2025, alleging that the company issued misleading guidance for 2025 despite being aware of significant industry challenges [4]. - The lawsuit claims that agilon overstated the positive financial impact from its strategic actions aimed at reducing risk [4]. Group 2: Company Events - On August 4, 2025, agilon announced the resignation of its President and CEO, Steven Sell, which was classified as a termination without cause [5]. - The same day, agilon reported its second-quarter results and acknowledged that industry headwinds were more severe than previously anticipated, leading to the suspension of its full-year 2025 financial guidance [5]. - Following these announcements, agilon's stock price fell by $0.94, or approximately 51.6%, from $1.82 to $0.88 per share [5].